Connect with us

Hi, what are you looking for?

News

Peso rises vs dollar on eased restrictions, findings on Pfizer’s COVID-19 treatment

THE PESO continued to strengthen versus the greenback on Monday on developments of a treatment for the coronavirus disease 2019 (COVID-19) and the relaxation of mobility restrictions in Metro Manila.

The local unit ended trading at P50.16 per dollar on Monday, appreciating by 17 centavos from its P50.33 close on Friday, data from the Bankers Association of the Philippines showed.

The currency’s Monday close is its strongest in more than a month or since it ended trading at P50.14 on Sept. 21.

The peso opened Monday’s session stronger than Friday’s close at P50.30 per dollar. Its weakest showing was at P50.34, while its intraday best was at P50.13 against the greenback.

Dollars exchanged dropped to $933.2 million on Monday from $1.2 billion on Friday.

The peso was backed by risk-on sentiment among investors following a report on progress in research for a COVID-19 treatment.

Reuters reported Friday that Pfizer, Inc.’s experimental antiviral pill was found to reduce chances of hospitalization or death by 89% for adults at risk of developing severe infection.

Pfizer’s pill, with the brand name Paxlovid, could secure US regulatory approval by the end of the year. Pfizer said it plans to submit interim trial results to the Food and Drug Administration before the Nov. 25 US Thanksgiving holiday. The trial was stopped early due to its high success rate.

President Joseph R. Biden said the US government has secured millions of doses of Pfizer’s drug.

Pfizer said it was currently expecting to manufacture more than 180,000 packs by the end of 2021 and at least 50 million packs by the end of 2022.

Meanwhile, a trader said the market was optimistic after the government decided to lift Metro Manila curfew hours last week.

Metro Manila officials lifted the general curfew in the area on Thursday after 19 months since the first lockdown in March 2020.

For Tuesday, Mr. Ricafort gave a forecast range of P50.10 to P50.30, while the trader expects the local unit to move within P50.20 to P50.45 per dollar. — L.W.T. Noble with Reuters

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

News

REUTERS TRADE Secretary Alfredo E. Pascual’s intention to join more free trade agreements received backing from major business chambers, who declared support for participating...

News

NATIONAL IRRIGATION ADMINISTRATION PHOTO RELEASE SUBSIDIES provided to government-owned and -controlled corporations (GOCCs) declined by 82.31% year on year to P7.905 billion in May,...

News

PHILIPPINE STAR/ MICHAEL VARCAS AGRICULTURE and fisheries planning needs to be more “bottom-up” to better meet the needs of farmers and fisherfolk, steering away...

News

REUTERS ERIC BROTEN had planned to sow about 5,000 acres of corn this year on his farm in North Dakota, but persistent springtime rains...

News

(First of two parts) Family-run businesses require structures that are necessary to ensure a smooth transition. In the Philippines, the wealth of ultra-high net...

News

THOUSANDS of supporters of President Ferdinand “Bongbong” R. Marcos, Jr. are unfazed by the rain during a free concert held in Manila on the...

You May Also Like

News

BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...

News

REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...

News

COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Financial Advisors

The healthcare ecosystem is one that has thrived on the cusp of scientific progress, benefitting enormously from the winds of change in the technological...

Disclaimer: Respect Investment.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.